These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20436264)

  • 1. Efficacy of recombinant human follicle stimulating hormone at low doses in inducing spermatogenesis and fertility in hypogonadotropic hypogonadism.
    Sinisi AA; Esposito D; Bellastella G; Maione L; Palumbo V; Gandini L; Lombardo F; De Bellis A; Lenzi A; Bellastella A
    J Endocrinol Invest; 2010 Oct; 33(9):618-23. PubMed ID: 20436264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone.
    Bouloux PM; Nieschlag E; Burger HG; Skakkebaek NE; Wu FC; Handelsman DJ; Baker GH; Ochsenkuehn R; Syska A; McLachlan RI; Giwercman A; Conway AJ; Turner L; van Kuijk JH; Voortman G
    J Androl; 2003; 24(4):604-11. PubMed ID: 12826700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.
    Sinisi AA; Esposito D; Maione L; Quinto MC; Visconti D; De Bellis A; Bellastella A; Conzo G; Bellastella G
    Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
    Rohayem J; Hauffa BP; Zacharin M; Kliesch S; Zitzmann M;
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism.
    Dwyer AA; Sykiotis GP; Hayes FJ; Boepple PA; Lee H; Loughlin KR; Dym M; Sluss PM; Crowley WF; Pitteloud N
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1790-5. PubMed ID: 24037890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin.
    Warne DW; Decosterd G; Okada H; Yano Y; Koide N; Howles CM
    Fertil Steril; 2009 Aug; 92(2):594-604. PubMed ID: 18930225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism.
    Nieschlag E; Bouloux PG; Stegmann BJ; Shankar RR; Guan Y; Tzontcheva A; McCrary Sisk C; Behre HM
    Reprod Biol Endocrinol; 2017 Mar; 15(1):17. PubMed ID: 28270212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men.
    Liu PY; Turner L; Rushford D; McDonald J; Baker HW; Conway AJ; Handelsman DJ
    Hum Reprod; 1999 Jun; 14(6):1540-5. PubMed ID: 10357972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults.
    Rohayem J; Sinthofen N; Nieschlag E; Kliesch S; Zitzmann M
    Andrology; 2016 Jan; 4(1):87-94. PubMed ID: 26779870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism.
    Matsumoto AM; Snyder PJ; Bhasin S; Martin K; Weber T; Winters S; Spratt D; Brentzel J; O'Dea L
    Fertil Steril; 2009 Sep; 92(3):979-990. PubMed ID: 18930190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin Treatment for the Male Hypogonadotropic Hypogonadism.
    Boeri L; Capogrosso P; Salonia A
    Curr Pharm Des; 2021; 27(24):2775-2783. PubMed ID: 32445446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
    Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience.
    Yang L; Zhang SX; Dong Q; Xiong ZB; Li X
    Int Urol Nephrol; 2012 Apr; 44(2):393-9. PubMed ID: 21989858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility induction in hypogonadotropic hypogonadal men.
    Prior M; Stewart J; McEleny K; Dwyer AA; Quinton R
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):712-718. PubMed ID: 30194850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis.
    Zacharin M; Sabin MA; Nair VV; Dabadghao P
    Fertil Steril; 2012 Oct; 98(4):836-42. PubMed ID: 22763096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
    Büchter D; Behre HM; Kliesch S; Nieschlag E
    Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of
    Firouzi V; Borjian Boroujeni P; Rokhsat Talab Z; Mohammadi M; Sadighi Gilani MA; Sabbaghian M; Mohseni Meybodi A
    Syst Biol Reprod Med; 2019 Aug; 65(4):326-332. PubMed ID: 31030566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. European Metrodin HP Study Group.
    Fertil Steril; 1998 Aug; 70(2):256-62. PubMed ID: 9696217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal therapy (hCG and rhFSH) for infertile men with adult-onset idiopathic hypogonadotropic hypogonadism.
    Kobori Y; Suzuki K; Iwahata T; Shin T; Sato R; Nishio K; Yagi H; Arai G; Soh S; Okada H
    Syst Biol Reprod Med; 2015 Apr; 61(2):110-2. PubMed ID: 25518839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.